Table 1 Changes in blood pressure, hepatic and renal biochemistry between metformin and non-metformin groups
From: Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes
Variables | Metformin | Non-metformin | P value | ||
|---|---|---|---|---|---|
Mean ± SD | N | Mean ± SD | N | ||
Blood glucose (mmol/L) | 6.41 ± 0.98 | 112 | 6.33 ± 0.90 | 169 | 0.4993 |
Systolic blood pressure (mmHg) | 133.29 ± 11.24 | 112 | 134.63 ± 9.43 | 169 | 0.2718 |
Diastolic blood pressure (mmHg) | 73.69 ± 7.23 | 112 | 74.22 ± 6.78 | 169 | 0.5271 |
Hemoglobin A1c (%) | 6.40 ± 0.57 | 112 | 6.29 ± 0.60 | 169 | 0.1260 |
Body mass index | 25.66 ± 3.64 | 112 | 25.18 ± 3.43 | 169 | 0.2584 |
Total cholesterol (mmol/L) | 4.71 ± 1.26 | 112 | 4.61 ± 0.90 | 169 | 0.4265 |
Triglyceride (mmol/L) | 1.90 ± 1.27 | 112 | 1.58 ± 0.99 | 169 | 0.0205 |
HDL(mmol/L) | 1.13 ± 0.30 | 87 | 1.16 ± 0.32 | 59 | 0.5051 |
LDL (mmol/L) | 2.66 ± 0.82 | 112 | 2.76 ± 0.81 | 169 | 0.3443 |
VLDL (mmol/L) | 0.81 ± 0.41 | 87 | 0.69 ± 0.45 | 59 | 0.0988 |
Creatinine (μmol/L) | 83.02 ± 17.49 | 112 | 85.89 ± 32.90 | 169 | 0.3979 |